3D Systems Partners with Klarity to Expand Access to Patient-Matched Radiotherapy Innovations
September 27 2023 - 8:30AM
Today, 3D Systems (NYSE:DDD) announced it has entered into a
partnership with Klarity, a world leader in solutions for radiation
therapy, to expand the distribution of its FDA-cleared VSP® Bolus
solution. Klarity will offer VSP Bolus within its new line of
high-quality patient-specific 3D printed products called Klarity
Prints™. Klarity Prints, powered by 3D Systems, is a service-based
line of 3D-printed radiotherapy accessories such as VSP Bolus,
which does not require specialized software or hardware, allowing
radiotherapy providers to focus on patient care.
3D Systems developed VSP Bolus to deliver 3D-printed,
biocompatible, patient-specific boluses that can improve therapy
modulation, decrease technician time, and enhance patient comfort.
Through the distribution agreement with Klarity, this innovative
3D-printed solution is now available to radiotherapy clinics across
the United States and Canada. Klarity’s team of experts is renowned
in the radiation oncology market for providing exceptional customer
service with a focus on delivering solutions to medical
professionals that improve cancer treatment. Once interested
clinics contact their Klarity Account Manager, orders can be
initiated quickly, and the patient-specific bolus is delivered
within a few days. The established workflow leveraging patient
treatment plans created by radiotherapy professionals frees
clinicians from the time-consuming task of manipulating objects in
specialized software and fabricating the accessory themselves. The
Klarity Prints VSP Bolus product is 3D printed to the exact
treatment plan bolus dimensions from a soft, biocompatible,
material that contours to the patient’s anatomy for an improved
treatment experience for providers and patients.
“This collaboration aligns perfectly with Klarity’s ongoing
commitment to improving the quality of care provided by our
customers,” said Peter Larson, CEO, Klarity. “As a North
American distributor of 3D Systems’ 3D-printed biocompatible bolus
products, we will be at the forefront of advancing personalized
care and improving the patient experience.”
Menno Ellis, 3D Systems’ EVP, Healthcare Solutions added,
“Klarity has a strong reputation in the radiation oncology sector
for delivering superior products and service. The company’s
commitment to improving patient care through treatment
personalization aligns with 3D Systems’ market-leading service
model for delivering high-quality 3D-printed, patient-specific
medical devices for over two decades. We’re pleased to partner with
Klarity to provide next-generation radiotherapy accessories to
patients undergoing treatment across the U.S. and Canada.”
3D Systems and Klarity will both participate in the 2023 ASTRO
Annual Meeting to be held October 1-4 at the San Diego Convention
Center in San Diego, California. Attendees interested in learning
more are invited to stop by 3D Systems’ booth #2353 or Klarity’s
booth #2317. For more information, please visit the 3D Systems or
Klarity websites.
Forward-Looking StatementsCertain statements
made in this release that are not statements of historical or
current facts are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to be materially
different from historical results or from any future results or
projections expressed or implied by such forward-looking
statements. In many cases, forward-looking statements can be
identified by terms such as "believes," "belief," "expects," "may,"
"will," "estimates," "intends," "anticipates" or "plans" or the
negative of these terms or other comparable terminology.
Forward-looking statements are based upon management’s beliefs,
assumptions, and current expectations and may include comments as
to the company’s beliefs and expectations as to future events and
trends affecting its business and are necessarily subject to
uncertainties, many of which are outside the control of the
company. The factors described under the headings "Forward-Looking
Statements" and "Risk Factors" in the company’s periodic filings
with the Securities and Exchange Commission, as well as other
factors, could cause actual results to differ materially from those
reflected or predicted in forward-looking statements. Although
management believes that the expectations reflected in the
forward-looking statements are reasonable, forward-looking
statements are not, and should not be relied upon as a guarantee of
future performance or results, nor will they necessarily prove to
be accurate indications of the times at which such performance or
results will be achieved. The forward-looking statements included
are made only as of the date of the statement. 3D Systems
undertakes no obligation to update or review any forward-looking
statements made by management or on its behalf, whether as a result
of future developments, subsequent events or circumstances or
otherwise, except as required by law.
About 3D Systems More than 35 years ago, 3D
Systems brought the innovation of 3D printing to the manufacturing
industry. Today, as the leading additive manufacturing solutions
partner, we bring innovation, performance, and reliability to every
interaction - empowering our customers to create products and
business models never before possible. Thanks to our unique
offering of hardware, software, materials, and services, each
application-specific solution is powered by the expertise of our
application engineers who collaborate with customers to transform
how they deliver their products and services. 3D Systems’ solutions
address a variety of advanced applications in healthcare and
industrial markets such as medical and dental, aerospace &
defense, automotive, and durable goods. More information on the
company is available at https://www.3dsystems.com.
About KlarityKlarity is at the forefront of
radiotherapy technology and innovation. Klarity’s superior products
and personalized service have established the company as a
worldwide leader, providing clinics with improved solutions for
patient positioning, treatment planning, brachytherapy, and custom
devices. https://www.klaritymedical.com.
Investor Contact: |
investor.relations@3dsystems.com |
Media Contact: |
press@3dsystems.com |
|
|
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/406733ae-d8b2-48e8-a5fb-acc69b4c9034
3D Systems (NYSE:DDD)
Historical Stock Chart
From May 2024 to Jun 2024
3D Systems (NYSE:DDD)
Historical Stock Chart
From Jun 2023 to Jun 2024